Enfusion, Inc. announced that Stephen Dorton has resigned from his position as chief financial officer, effective January 6, 2023, in order to pursue another career opportunity, and not due to any disagreement with the company's operations, policies or practices. Mr. Movchan also noted that, as part of its succession planning strategy, the company maintains relationships with a number of executive search firms. He indicated that the Board of Directors had initiated discussions with several qualified CFO candidates and would conduct a search until such time as a new CFO is appointed.